This document provides an overview of liposomes and niosomes. It discusses the structure and components of liposomes, how they were first produced, and common phospholipids and cholesterol used. Various preparation methods for liposomes are described, including mechanical dispersion, extrusion, ethanol injection, and reverse phase evaporation. Characterization techniques and applications of liposomes in drug delivery, gene delivery, and cancer treatment are also summarized. The document concludes by comparing liposomes and niosomes, describing advanced preparation methods for niosomes, and their applications in areas like transdermal delivery and cancer.
Liposomes-Classification, methods of preparation and application Vijay Hemmadi
liposome preparation and application
A liposome is a tiny bubble (vesicle), made out of the same material as a cell membrane. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases. Membranes are usually made of phospholipids, which are molecules that have a head group and a tail group
“Microparticles are defined as particulate dispersions or solid particles with a size in the range of 1-1000 μm.”
The drug is dissolved, entrapped, encapsulated or attached to a microparticle matrix.
Various approaches to Targeted Drug Delivery Systems (TDDS) in its formuation and evaluation in a pharmaceutical industry and research is outlined in this presentation.
Liposomes-Classification, methods of preparation and application Vijay Hemmadi
liposome preparation and application
A liposome is a tiny bubble (vesicle), made out of the same material as a cell membrane. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases. Membranes are usually made of phospholipids, which are molecules that have a head group and a tail group
“Microparticles are defined as particulate dispersions or solid particles with a size in the range of 1-1000 μm.”
The drug is dissolved, entrapped, encapsulated or attached to a microparticle matrix.
Various approaches to Targeted Drug Delivery Systems (TDDS) in its formuation and evaluation in a pharmaceutical industry and research is outlined in this presentation.
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
Gastro retentive drug delivery system (GRDDS)Shweta Nehate
Oral route is the most acceptable route for drug administration. Apart from conventional dosage forms several other forms were developed in order to enhance the drug delivery for prolonged time period and for delivering drug to a particular target site. Gastro-retentive drug delivery system (GRDDS) has gainned immense popularity in the field of oral drug delivery recently. it is a widely employed approach to retain the dosage form in the stomach for an extended period of time and release the drug slowly that can address many challenges associated with conventional oral delivery, including poor bioavailability. different innovative approaches are being applied to fabricate GRDDS. Gastroretentive drug delivery is an approach to prolong gastric residence time, there by targeting site-specific drugs release in the upper gastrointestinal tract (GIT) for local or systemic effects. It is obtained by retaining dosage form into stomach and by releasing the in controlled manner.
Easy & to the point Topics are clearly given in this presentation..
Thanks & Best Regard
(Anurag Pandey) B.Pharm
Contact :- anurag.dmk05@gmail.com (Facebook & Gmail both)
‘Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.’
Introduction
Structure
Niosomes Vs. Liposome
Advantages & Disadvantages
Properties of Niosomes
Method of Manufacturing
Evaluation of Niosomes
Applications
Marketed products
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
Gastro retentive drug delivery system (GRDDS)Shweta Nehate
Oral route is the most acceptable route for drug administration. Apart from conventional dosage forms several other forms were developed in order to enhance the drug delivery for prolonged time period and for delivering drug to a particular target site. Gastro-retentive drug delivery system (GRDDS) has gainned immense popularity in the field of oral drug delivery recently. it is a widely employed approach to retain the dosage form in the stomach for an extended period of time and release the drug slowly that can address many challenges associated with conventional oral delivery, including poor bioavailability. different innovative approaches are being applied to fabricate GRDDS. Gastroretentive drug delivery is an approach to prolong gastric residence time, there by targeting site-specific drugs release in the upper gastrointestinal tract (GIT) for local or systemic effects. It is obtained by retaining dosage form into stomach and by releasing the in controlled manner.
Easy & to the point Topics are clearly given in this presentation..
Thanks & Best Regard
(Anurag Pandey) B.Pharm
Contact :- anurag.dmk05@gmail.com (Facebook & Gmail both)
‘Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.’
Niosomes :it is A Novel Drug Delivery System (NDDS) advantages and dissadvatages ,structures of niosomes,methods of preparation along with applications of niosomes
Niosomes are vesicles composed mainly of hydrated non-ionic surfactant with or without cholesterol used for targetted drug delivery. Niosomes are better than liposomes as they are cost effective, stable, and can be stored for a long period of time.
Liposomes are defined as phospholipid vesicles consisting of one or more concentric lipid bilayers enclosing discrete aqueous spaces. The unique ability of liposomal systems to entrap both lipophilic and hydrophilic compounds enables a diverse range of drugs to be encapsulated by these vesicles.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Liposome and Niosome
1. PRESENTED BY- GUIDED BY-
Mr. Shubham J. Gore Dr. V.V. Pande
F.Y.M Pharm HOD of Pharmaceutics
(Pharmaceutics) Department.
Sanjivani College of Pharmaceutical Education and Research,
Kopargaon.
116 March 2018
2. Introduction
Structure & components
Classification
Mechanism
Method of preparation
Characterization
Uses
List of marketed product
Niosome
Diff.between liposome & niosome
Advanced method of niosome
Application
Recent advances in niosome
Conclusion
References
216 March 2018
3. liposomes are simple, microscopic, concentric bilayered
vesicles in which an aqueous volume is entirely
enclosed by a membraneous lipid bilayer mainly
composed of natural or synthetic phospholipids.
Liposomes were first produced in England in 1961 by
Alec D. Bangham.The size of a liposome ranges from
some 20 nm up to several micrometers.
Phospholipid + Cholesterol
316 March 2018
5. Phospholipid
Phospholipid are amphipathic molecule i.e. having affinity for both
aqueous & polar moieties, as they have a hydrophobic tail & hydrophillic
head.
Hydrophilic polar head-
Phosphoric acid bound to water soluble molecule.
Hydrophobic tail-
2 fatty acid chain containing 10-24 carbon atoms and 0-6 double bond in
each chain.
Naturally occurring phospholipids used are :
PC: Phosphatidyl choline.(lecithin)
PE: Phosphatidyl ethanolamine.(cephalin)
PS: Phosphatidylserine
516 March 2018
6. Synthetic phospholipids used are:
DOPC: Dioleoyl phosphatidyl choline
DSPC: Disteroyl phosphatidyl choline
DOPE: Dioleoyl phosphatidyl ethanolamine
DSPE: Distearoyl phosphatidyl ethanolamine
Cholesterol
Cholesterol stabilizes the Membrane
Steroid lipid
Interdigitates between phospholipids
It’s decreases the fluidity in bilayer
616 March 2018
12. General Method Of Liposome Preparation
12
Drying down lipid from organic solvent
Dispersion of lipid in aqueous media
Purification of resultant liposome
Analysis of final product
16 March 2018
13. Mechanical Dispersion Method.
13
Lipid dissolve in organic solvent/co-solvent
Remove organic solvent under vacuum
Film deposition
Solid lipid mixture is hydrated by using aqueous buffer
Lipid spontaneously swell & Hydrate
Liposome
16 March 2018
14. There are four basic method for mechanical
dispersion.
Hand shaking method.
Non shaking method.
Pro –liposomes .
Freeze drying .
1416 March 2018
24. Extrusion of preformed
large liposomes in french
press under very high
pressure .
uni or oligo lamellar
liposomes of intermediate
size (30-80nm ) .
Advantages
Less leakage and more
stable liposomes are
formed compared to
sonicated forms.
2416 March 2018
25. The size of
liposomes is reduced
by gently passing
them through
polycarbonate
membrane filter of
defined pore size at
lower pressure
Used for preparation
of LUVs and MLVs
2516 March 2018
27. 27
Lipid dissolved in organic solvent
Excess addition of aqueous phase
Lipid allign at interface of aqueous and organic layer
Formation of monolayer and bilayer of phospholipid
LIPOSOME
16 March 2018
28. Ether Injection
Lipid +ether solution in
syringe
Inject slowly
In the aqueous phase
Large unilamellar
vesicle
28
Ethanol injection
Lipid+ethanol solution in
the syringe
Inject rapidly
In the aqueous phase
Small unilamellar vesicle
16 March 2018
29. Organic solution +Lipid+aqueous phase
Emulsion
Hot aqueous solution of buffer
Multi compartment vesicle W/O/W (double
emulsion)
LUVs
2916 March 2018
31. Below CMC detergent molecules exist in free
solution.As the conc.is increased , micelle
are formed.
31
Phospholipid brought into intimate contact with aqueous phase
By addition optimized conc.of detergent
Formation of micelle (LIPOSOME)
16 March 2018
34. In gene delivery.
As drug delivery carriers.
Enzyme replacement therapy.
Chelation therapy for treatment of heavy metal
poisoning.
Liposomes in antiviral/anti microbial therapy.
In multi drug resistance.
In tumour therapy.
In immunology.
In cosmetology
3416 March 2018
37. INTRODUCTION
Niosomes are a novel drug delivery system, in which
the medication is encapsulated in a vesicle.
The vesicle is composed of a bilayer of non-ionic
surface active agents and hence the name niosomes.
The niosomes are very small, and microscopic in size.
Their size lies in the nanometric scale.
materials have been used to form niosomes such as
sucrose ester surfactants and polyoxyethylene alkyl
ether surfactants, alkyl ester, alkyl amides, fatty acids
and amino acid compound.
3716 March 2018
38. Ester bonds of phospholipids are
easily hydrolyzed, this can lead to
phosphoryl migration at low PH.
Peroxidation of unsaturated
phospholipids.
As liposomes have purified
phospholipids they are to be stored
and handled at inert(N2)
atmospheres where as Niosomes
are are made of non ionic
surfactants and are easy to handle
and store.
Phospholipid raw materials are
naturally occurring substances and
as such require extensive
purification thus making them
costly. 3816 March 2018
40. Hand Shaking method
Reverse phase evaporation technique
Ether Injection method
Multiple membrane extrusion method
Bubble method
Sonication
From Proniosomes
4016 March 2018
41. BUBBLE METHOD
It is novel technique
for the one step
preparation of
liposomes and
niosomes without the
use of organic
solvents.
RBF as bubbling unit with
three necks in water bath.
Reflux , thermometer and
nitrogen supply by three
necks
Cholesterol+ Surfactant
dispersed in buffer pH 7.4
at 70°C
Above dispersion is
homogenized for 15 sec and
then bubbled with nitrogen
gas at 70°C to get niosomes
4116 March 2018
42. 42
Formation of niosomes from proniosomes:
It is prepared by coating water-soluble carrier such as
sorbitol with surfactant. The result of the coating process
is a dry formulation. In which each water-soluble particle
is covered with a thin film of dry surfactant.This
preparation is termed “Proniosomes
16 March 2018
43. Transdermal
parenteral
Radiopharmaceuticals
Opthalmic drug delivery
Leishmeniasis
Cancer
Diagnostic imaging
- Visual representation of the fuction of organ.
4316 March 2018
44. Combination of PEG and glucose conjugates on the surface of
niosomes significantly improved tumor targeting of an
encapsulated paramagnetic agent assessed with MR imaging in a
human carcinoma xenograft model.
Phase I and phase II studies were conducted for Niosomal
methotrexate gel in the treatment of localized psoriasis. These
studies suggest that niosomal methotrexate gel is more
efficacious than placebo and marketed methotrexate gel.
A research article was published that Acyclovir entrapped
niosomes were prepared by Hand shaking and Ether injection
methods increases the oral bioavailability.
Lancome has come out with a variety of anti-ageing products
which are based on niosome formulations.
4416 March 2018
45. The concept of incorporating the drug into liposomes or
niosomes for a better targeting of the drug at appropriate tissue
destination is widely accepted by researchers and academicians.
Niosomes represent a promising drug delivery module.
Niosomes are thoughts to be better candidates drug delivery as
compared to liposomes due to various factors like cost, stability
etc .
Various type of drug deliveries can be possible using niosomes
like targeting, ophthalmic, topical, parenteral, etc.
Niosomes can also serve better aid in diagnostic imaging and
vaccine adjuvant in pharmaceutical industry.s
4516 March 2018
46. S.P. Vyas And R.K. Khar,targeted & Controlled Drug
Delivery,liposomes,173-279.
Avinash Kumar Seth and Ambika Nandan Misra (2007),“Preparation
and evaluation of Acyclovir Liposome’s by two techniques a
comparative study”, Indian Journal of Pharmaceutical sciences, Vol. 6,
No. 2, pp.75-81
Himanshu Anwekar, Liposome- as drug carriers, International Journal
Of Pharmacy & Life Sciences, Vol.2, Issue 7: July: 2011, 945-951
Upendra Bulbake , Sindhu Doppalapudi,Review on Liposomal
Formulations in Clinical Use:Pharmaceutics, Published: 27 March
2017.
4616 March 2018